Picture of Arecor Therapeutics logo

AREC — Arecor Therapeutics Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+1.12%
3m+2.16%
6m-7.01%
1yrn/a
Volume Change (%)
10d/3m-36.72%
Price vs... (%)
52w High-19.49%
50d MA-0.46%
200d MA+3.61%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-34.52%
Return on Equity-63.85%
Operating Margin-556.04%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Arecor Therapeutics EPS forecast chart

Profile Summary

Arecor Therapeutics PLC is a United Kingdom-based biopharmaceutical company. The Company targets improving patient care by bringing medicines to market through the existing therapeutic products. It partners with global pharmaceutical and biotechnology companies to apply the Arestat technology to their products under a technology licensing model. These products can be at any stage in development from early phase clinical development through to products that are already on the market. The areas of applications of the technology are biologicals, biosimilars, therapeutic vaccines and therapeutic peptides.

Directors

    Last Annual
    December 31st, 2021
    Last Interim
    December 31st, 2021
    Incorporated
    April 13th, 2021
    Public Since
    December 7th, 2021
    No. of Employees
    30
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    27,835,024
    Blurred out image of a map
    Address
    Chesterford Research Park, SAFFRON WALDEN, CB10 1XL
    Web
    Phone
    Auditors
    Grant Thornton UK LLP

    AREC Share Price Performance

    Similar to AREC

    Picture of 4Basebio logo

    4Basebio

    gb flag iconLondon Stock Exchange

    Picture of 4d Pharma logo

    4d Pharma

    gb flag iconLondon Stock Exchange

    Picture of Allergy Therapeutics logo

    Allergy Therapeutics

    gb flag iconLondon Stock Exchange

    Picture of Avacta logo

    Avacta

    gb flag iconLondon Stock Exchange

    Picture of Bioventix logo

    Bioventix

    gb flag iconLondon Stock Exchange

    FAQ

    Or unlock with your email

    Or unlock with your email